Citation: | ZHU Rong, WANG Guanshun, ZHANG Ya, LI Ruiqian, YANG Yinrui, SHEN Jing, GU Shangwei. Research progress of quantitative functional magnetic resonance imaging in prostate cancer[J]. Chinese Journal of General Practice, 2024, 22(12): 2104-2107. doi: 10.16766/j.cnki.issn.1674-4152.003808 |
[1] |
SUNG H, FERLAY J, SIEGEL R L, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. doi: 10.3322/caac.21660
|
[2] |
李星, 曾晓勇. 中国前列腺癌流行病学研究进展[J]. 肿瘤防治研究, 2021, 48(1): 98-102.
LI X, ZENG X Y. Advances in epidemiology of prostate cancer in China[J]. Cancer Res Prev Treat, 2021, 48(1): 98-102.
|
[3] |
MOTTET N, VAN DEN BERGH R C N, BRIERS E, et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent[J]. Eur Urol, 2021, 79(2): 243-262. doi: 10.1016/j.eururo.2020.09.042
|
[4] |
黄泽海, 黄晓敏, 陈泽荣, 等. 3D腹腔镜与2D腹腔镜下腹膜外前列腺癌根治术双中心回顾性队列研究[J]. 中华全科医学, 2022, 20(6): 919-922. doi: 10.16766/j.cnki.issn.1674-4152.002487
HANG Z H, HUANG X M, CHEN Z R, et al. Three-dimensional versus two-dimensional imagine systems in extraperitoneal radical prostatectomy for prostate cancer: a bicenter and retrospective cohort study[J]. Chinese Journal of General Practice, 2022, 20(6): 919-922. doi: 10.16766/j.cnki.issn.1674-4152.002487
|
[5] |
刘晓燕, 王宝剑, 张娟, 等. 酰胺质子转移成像原理及其在脑胶质瘤中的研究进展[J]. 磁共振成像, 2022, 13(2): 127-129.
LIU X Y, WANG B J, ZHANG J, et al. Principle of amide proton transfer imaging and its research progress in glioma[J]. Chin J Magn Reson Imaging, 2022, 13(2): 127-129.
|
[6] |
PIHLSTRØM N, JIN Y, NENSETH Z, et al. STAMP2 expression mediated by cytokines attenuates their growth-limiting effects in prostate cancer cells[J]. Cancers (Basel), 2021, 13(7): 1579. DOI: 10.3390/cancers13071579.
|
[7] |
YANG L, WANG L, TAN Y C, et al. Amide Proton Transfer-weighted MRI combined with serum prostate-specific antigen levels for differentiating malignant prostate lesions from benign prostate lesions: a retrospective cohort study[J]. Cancer Imaging, 2023, 23(1): 3. DOI: 10.1186/s40644-022-00515-w.
|
[8] |
GUO Z X, QIN X Y, MU R H, et al. Amide proton transfer could provide more accurate lesion characterization in the transition zone of the prostate[J]. J Magn Reson Imaging, 2022, 56(5): 1311-1319. doi: 10.1002/jmri.28204
|
[9] |
胡文君, 刘爱连, 陈丽华, 等. 酰胺质子转移成像联合T2-mapping鉴别前列腺癌与前列腺增生的价值[J]. 放射学实践, 2022, 37(11): 1416-1421.
HU W J, LIU A L, CHEN L H, et al. The value of amide proton transfer imaging combined with T2-mapping for differentiating prostate cancer from benign prostatic hyperplasia[J]. Chin J Magn Reson Imaging, 2022, 37(11): 1416-1421.
|
[10] |
任雪, 刘爱连, 陈丽华, 等. APT联合mDIXON-Quant成像对前列腺癌和前列腺增生的鉴别诊断价值[J]. 放射学实践, 2023, 38(1): 58-64.
REN X, LIU A L, CHEN L H, et al. The value of APT combined with mDIXON-Quant imaging in the differential diagnosis of prostate cancer and benign prostatic hyperplasia[J]. Radiol Practice, 2023, 38(1): 58-64.
|
[11] |
YIN H J, WANG D D, YAN R F, et al. Comparison of diffusion kurtosis imaging and amide proton transfer imaging in the diagnosis and risk assessment of prostate cancer[J]. Front Oncol, 2021, 11: 640906. DOI: 10.3389/fonc.2021.640906.
|
[12] |
李茜玮, 陈丽华, 王楠, 等. 初探酰胺质子加权联合mDixon-Quant序列评估前列腺癌骨转移的价值[J]. 中国临床医学影像杂志, 2022, 33(8): 540-545.
LI X W, CHEN L H, WANG N, et al. Preliminary study on the application of amide protontransfer-weighted combined with mDixon-Quant imaging in differentiating bone metastasis of prostate cancer[J]. Chin Clin Med Imaging, 2022, 33(8): 540-545.
|
[13] |
张鹏运, 汤芸行, 姜昊洋, 等. 三维酰胺质子转移成像鉴别前列腺癌伴骨转移与不伴骨转移的可行性研究[J]. 磁共振成像, 2022, 13(12): 100-103, 110.
ZHANG P Y, TANG Y X, JIANG H Y, et. al. Feasibility study of three-dimensional amide proton transfer imaging in differentiating prostate cancer with and without bone metastasis[J]. Chin J Magn Reson Imaging, 2022, 13(12): 100-103, 110.
|
[14] |
ZABIHZADEH M, FATAHI ASL J, FARZANEGAN Z, et al. Accuracy of magnetic resonance spectroscopy techniques in prostate cancer and prostatitis[J]. Arch Iran Med, 2020, 23(2): 104-112.
|
[15] |
GHOLIZADEH N, GREER P B, SIMPSON J, et al. Diagnosis of transition zone prostate cancer by multiparametric MRI: added value of MR spectroscopic imaging with sLASER volume selection[J]. J Biomed Sci, 2021, 28(1): 54. DOI: 10.1186/s12929-021-00750-6.
|
[16] |
TAVAKOLI A A, HIELSCHER T, BADURA P, et al. Contribution of dynamic contrast-enhanced and diffusion MRI to PI-RADS for detecting clinically significant prostate cancer[J]. Radiology, 2023, 306(1): 186-199.
|
[17] |
SCIALPI M, MARTORANA E, SCALERA G B, et al. Apparent diffusion coefficient and lesion volume to detect prostate cancer[J]. Radiology, 2023, 307(3): e222177. DOI: 10.1148/radiol.222177.
|
[18] |
WEN B H, ZHANG Z X, ZHU J, et al. Apparent diffusion coefficient map-based radiomics features for differential diagnosis of pleomorphic adenomas and warthin tumors from malignant tumors[J]. Front Oncol, 2022, 12: 830496. DOI: 10.3389/fonc.2022.830496.
|
[19] |
SUROV A, MEYER H J, WIENKE A. Correlations between apparent diffusion coefficient and Gleason score in prostate cancer: a systematic review[J]. Eur Urol Oncol, 2020, 3(4): 489-497.
|
[20] |
MANETTA R, PALUMBO P, GIANNERAMO C, et al. Correlation between ADC values and Gleason score in evaluation of prostate cancer: multicentre experience and review of the literature[J]. Gland Surg, 2019, 8(Suppl 3): S216-S222.
|
[21] |
邢朋毅, 宋涛, 王铁功, 等. 基于双参数磁共振成像影像组学机器学习的前列腺癌风险分层[J]. 第二军医大学学报, 2021, 42(3): 233-242.
XING P Y, SONG T, WANG T G, et al. Risk stratification of prostate cancer based on biparametric magnetic resonance imaging radiomics machine learning[J]. Academic Journal of Second Military Medical University, 2021, 42(3): 233-242.
|
[22] |
徐嬿, 杨贤卫, 王千里, 等. IVIM-DWI定量分析对扶正消瘀散结方联合内分泌治疗Ⅲ、Ⅳ期前列腺癌疗效的评估研究[J]. 临床放射学杂志, 2022, 41(10): 1926-1930.
XU Y, YANG X W, WANG Q L, et al. Quantitative diagnostic value of IVIM-MRI to evaluate the efficacy in Fuzheng Xiaoyu Sanjie combined with endocrine treatment for Ⅲ, Ⅳ stage-prostate cancer[J]. Clinical Radiology, 2022, 41(10): 1926-1930.
|
[23] |
程昊, 李春媚. 前列腺MRI的新技术进展[J]. 中国医学影像学杂志, 2023, 31(4): 418-423.
CHENG H, LI C M. Development of new technology of prostate magnetic resonance imaging[J]. Chinese Journal of Medical Imaging, 2023, 31(4): 418-423.
|
[24] |
BEYHAN M, SADE R, KOC E, et al. The evaluation of prostate lesions with IVIM DWI and MR perfusion parameters at 3T MRI[J]. Radiol Med, 2019, 124(2): 87-93.
|
[25] |
YAO W G, LIU J, ZHENG J J, et al. Study on diagnostic value of quantitative parameters of intravoxel incoherent motion diffusion-weighted imaging (IVIM-DWI) in prostate cancer[J]. Am J Transl Res, 2021, 13(4): 3696-3702.
|
[26] |
郭定波, 曾国飞, 杨华, 等. 体素内不相干运动扩散加权成像在前列腺癌鉴别诊断及Gleason分级中应用的Meta分析[J]. 磁共振成像, 2022, 13(2): 69-74.
GUO D B, ZENG G F, YANG H, et al. Intravoxel incoherent motion diffusion-weighted imaging for assessment of the differential diagnosis and Gleason grade in prostate cancer: a meta-analysis[J]. Chin J Magn Reson Imaging, 2022, 13(2): 69-74.
|
[27] |
CHEN Z W, XUE Y N, ZHANG Z, et al. The performance of intravoxel-incoherent motion diffusion-weighted imaging derived hypoxia for the risk stratification of prostate cancer in peripheral zone[J]. Eur J Radiol, 2020, 125: 108865. DOI: 10.1016/j.ejrad.2020.108865.
|
[28] |
RIEXINGER A, MARTIN J, WETSCHEREK A, et al. An optimized b-value distribution for triexponential intravoxel incoherent motion (IVIM) in the liver[J]. Magn Reson Med, 2021, 85(4): 2095-2108.
|
[29] |
ABREU-GOMEZ J, LIM C, CRON G O, et al. Pharmacokinetic modeling of dynamic contrast-enhanced (DCE)-MRI in PI-RADS category 3 peripheral zone lesions: preliminary study evaluating DCE-MRI as an imaging biomarker for detection of clinically significant prostate cancers[J]. Abdom Radiol (NY), 2021, 46(9): 4370-4380.
|
[30] |
MICHALLEK F, HUISMAN H, HAMM B, et al. Prediction of prostate cancer grade using fractal analysis of perfusion MRI: retrospective proof-of-principle study[J]. Eur Radiol, 2022, 32(5): 3236-3247.
|
[31] |
罗拥志, 王习. 动态对比增强磁共振成像联合扩散加权成像对前列腺中央腺体癌的诊断价值[J]. 磁共振成像, 2021, 12(9): 61-64.
LUO Y Z, WANG X. Diagnostic value of DCE-MRI combined with DWI for central gland prostate cancer[J]. Chin J Magn Reson Imaging, 2021, 12(9): 61-64.
|
[32] |
李新瑜, 刘晴晴, 李明霞, 等. 高b值表观扩散系数与动态增强磁共振定量参数对移行带前列腺癌的诊断价值[J]. 中国医学影像学杂志, 2023, 31(10): 1096-1100, 1108.
LI X Y, LIU Q Q, LI M X, et al. Diagnostic value of high b value apparent diffusion coefficient and dynamic contrast enhanced magnetic resonance quantitative parameters in transitional zone prostate cancer[J]. Chinese Journal of Medical Imaging, 2023, 31(10): 1096-1100, 1108.
|
[33] |
MICHALLEK F, HUISMAN H, HAMM B, et al. Accuracy of fractal analysis and PI-RADS assessment of prostate magnetic resonance imaging for prediction of cancer grade groups: a clinical validation study[J]. Eur Radiol, 2022, 32(4): 2372-2383.
|